Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
Nephrology Practice Solutions Names New Chief Medical Officer
Nephrology Practice Solutions (NPS) today announced that Dr. Thao Truong Pascual has assumed the role of chief medical officer (CMO). As a subsidiary of DaVita, NPS owns or manages nephrology…
-
DaVita Inc. Announces Pricing of $1.75 Billion Senior Notes Offering
DaVita Inc. (NYSE: DVA) (“DaVita”) announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the “2030 notes”)….
-
DaVita Inc. Announces Offering of $1.75 Billion Senior Notes
DaVita Inc. (NYSE: DVA) (“DaVita”) announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the “2030 notes”), subject to…
-
DaVita Continues to Support Teammates during COVID-19 Crisis
DaVita Kidney Care recently announced its continued support for U.S. employees, known as teammates, during the COVID-19 pandemic by implementing and strengthening programs specifically created to…
-
DaVita Inc. COVID-19 Response Efforts and 1st Quarter 2020 Results
During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its…